# FDA 483 - L'OREAL USA, INC. - June 24, 2022

Source: https://www.globalkeysolutions.net/records/483/loreal-usa-inc/6f654aaa-0ae3-41f9-ae32-a3fdd986012c

> FDA 483 for L'OREAL USA, INC. on June 24, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: L'OREAL USA, INC.
- Inspection Date: 2022-06-24
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: L'OREAL USA, INC. in N Little Rock, AR, an OTC drug and cosmetic manufacturer, was cited for three observations during an FDA inspection. The firm failed to follow quality control unit procedures regarding record keeping and retention, did not perform routine equipment calibration within established timeframes, and lacked proper documentation for second-person review of cleaning logs. These issues indicate deficiencies in the firm's quality system and adherence to its own written procedures.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)

Company: https://www.globalkeysolutions.net/companies/loreal-usa-inc/7d3b71d5-dca8-478c-ac59-221294019eda

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab